Gallus BioPharmaceuticals Utilizes ambr15 Micro Bioreactor

Product News   May 06, 2014

 
Gallus BioPharmaceuticals Utilizes ambr15 Micro Bioreactor
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Gyros Protein Technologies Introduces New ADA Solution for Immunogenicity Market

Product News

Gyros Protein Technologies launches a new version of its anti-drug antibody solution for the immunogenicity market.

READ MORE

Horizon Discovery Takes Exclusive License for Transposon-based Gene Editing Technology Platform

Product News

Horizon announces completion of exclusive license, broadening the companies gene editing capabilities.

READ MORE

Arcinova Use FlowSyn for Efficient Scale-Up of Challenging Batch Processes

Product News

Arcinova has invested in a FlowSyn™ continuous flow reactor enabling them to develop and simplify the scale-up of a challenging API batch process.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE